These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17696805)

  • 1. In vitro models for processes involved in intestinal absorption.
    Nigsch F; Klaffke W; Miret S
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):545-56. PubMed ID: 17696805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive approaches to increase absorption of compounds during lead optimisation.
    Valko K; Butler J; Eddershaw P
    Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a biophysical drug absorption model by the PATQSAR system.
    Bermejo M; Merino V; Garrigues TM; Pla Delfina JM; Mulet A; Vizet P; Trouiller G; Mercier C
    J Pharm Sci; 1999 Apr; 88(4):398-405. PubMed ID: 10187749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.
    Fliszar KA; Hill BT; Foster N
    J Pharm Sci; 2007 Aug; 96(8):2161-70. PubMed ID: 17387695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability characteristics of various intestinal regions of rabbit, dog, and monkey.
    Jezyk N; Rubas W; Grass GM
    Pharm Res; 1992 Dec; 9(12):1580-6. PubMed ID: 1488401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
    Bergström CA
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.
    Hurst S; Loi CM; Brodfuehrer J; El-Kattan A
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):469-89. PubMed ID: 17696800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability and its relevance for absorption and elimination.
    Lennernäs H
    Xenobiotica; 2007; 37(10-11):1015-51. PubMed ID: 17968735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mucus models for investigation of intestinal absorption mechanisms. 2. Mechanisms of drug interactions with intestinal mucus].
    Matthes I; Nimmerfall F; Sucker H
    Pharmazie; 1992 Aug; 47(8):609-13. PubMed ID: 1438513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
    Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
    Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity.
    Stenberg P; Luthman K; Ellens H; Lee CP; Smith PL; Lago A; Elliott JD; Artursson P
    Pharm Res; 1999 Oct; 16(10):1520-6. PubMed ID: 10554092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High lipophilicity decreases drug transport across intestinal epithelial cells.
    Wils P; Warnery A; Phung-Ba V; Legrain S; Scherman D
    J Pharmacol Exp Ther; 1994 May; 269(2):654-8. PubMed ID: 8182532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which in vitro screens guide the prediction of oral absorption and volume of distribution?
    van de Waterbeemd H
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):162-6. PubMed ID: 15733210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucus models for investigation of intestinal absorption mechanisms. 4. Comparison of mucus models with absorption models in vivo and in situ for prediction of intestinal drug absorption].
    Matthes I; Nimmerfall F; Vonderscher J; Sucker H
    Pharmazie; 1992 Oct; 47(10):787-91. PubMed ID: 1480659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.